510(k) device
TYRX Absorbable Antibacterial Envelope (medium)
Medtronic, Inc. · Mesh, Surgical, Polymeric (FTL, Class II) · First FDA decision Apr 24, 2018, newest Mar 27, 2020Hernia
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
2
510(k) pathway
Device trials
2
Naming "TYRX Absorbable Antibacterial"
MAUDE reports
789
Brand "TYRX Absorbable Antibacterial", since 2015
PubMed studies
17
Mentioning "TYRX Absorbable Antibacterial"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing TYRX Absorbable Antibacterial Envelope (medium)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 2 of 2 decisions filed under this name.
- TYRX Absorbable Antibacterial Envelope (medium), TYRX Absorbable Antibacterial Envelope (large)510(k)
K192389 · Decided Mar 27, 2020 · 206 days after receipt
Device type: Mesh, Surgical, Polymeric (FTL) · General & Plastic Surgery
- TYRX Absorbable Antibacterial Envelope (medium), TYRX Absorbable Antibacterial Envelope (large)510(k)
K180030 · Decided Apr 24, 2018 · 111 days after receipt
Device type: Mesh, Surgical, Polymeric (FTL) · General & Plastic Surgery
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "TYRX Absorbable Antibacterial", any status and sponsor, newest update first.
- Analysis of Clinical Application of China's First Batch of TYRX Absorbable Antibacterial EnvelopeActive, not recruiting
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityAcademic, hospital or other
NCT06710873 · 50 participants · Start Dec 1, 2023 · Primary completion Oct 9, 2024
Device: TYRX Absorbable Antibacterial Envelope · For: CIED Infection; TYRX Absorbable Antibacterial Envelope
Sites: Guangzhou, China
- World-wide Randomized Antibiotic Envelope Infection Prevention TrialPivotal-lookingCompleted
Medtronic Cardiac Rhythm and Heart FailurePublic (MDT)
NCT02277990 · 7,075 participants · Start Jan 2015 · Primary completion Sep 2018
Device: TYRX™ Absorbable Antibacterial Envelope · For: CIED Related Infection
Sites: Anchorage, Alaska; Mesa, Arizona; Scottsdale, Arizona · 181 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "TYRX Absorbable Antibacterial", and for the whole product code for context.
This brand
789 reports: 32 malfunction, 744 injury, 13 death
Whole product code FTL
111,758 reports: 2,258 malfunction, 108,801 injury, 604 death
Newest reports for this brand
2182208-2026-62173 · Received Oct 28, 2026 · Event dated Oct 8, 2026
Device type: Mesh, Surgical, Polymeric (FTL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Medical device site infection
2182207-2026-03016 · Received Oct 27, 2026 · Event dated Oct 1, 2026
Device type: Mesh, Surgical, Polymeric (FTL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Bacterial Infection
2182208-2026-61786 · Received Oct 27, 2026 · Event dated Apr 21, 2026
Device type: Mesh, Surgical, Polymeric (FTL)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Bacterial Infection
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "TYRX Absorbable Antibacterial"[tiab]. The summary above synthesizes these.
- Cost-effectiveness of TYRX absorbable antibacterial envelope for prevention of cardiovascular implantable electronic device infection.
Kay G, Eby EL, Brown B, et al. · J Med Econ · 2018
- Critical Analysis of the TYRX Absorbable Antibacterial Envelope's Impact on Device Pocket Healing.
Rasheed MA, Rasheed AB, Bajwa U, et al. · J Cardiovasc Electrophysiol · 2025Letter
- Effects of envelopes on cardiac implantable electronic device pocket healing: A head-to-head preclinical evaluation.
Virmani R, Philippon F, Mittal S, et al. · Heart Rhythm · 2024Research Support, Non-U.S. Gov't
- Response to: Critical Analysis of the TYRX Absorbable Antibacterial Envelope's Impact on Device Pocket Healing.
Philippon F, Virmani R, Finn AV · J Cardiovasc Electrophysiol · 2025Letter
- Preclinical evaluation of a third-generation absorbable antibacterial envelope.
Love CJ, Hanna I, Thomas G, et al. · Heart Rhythm · 2023Research Support, Non-U.S. Gov't
- An antibiotic envelope to reduce infections in deep brain stimulation surgery.
Primalani N, Lan LC, Ang SYL, et al. · J Clin Neurosci · 2023
- The World-wide Randomized Antibiotic Envelope Infection Prevention (WRAP-IT) trial: Long-term follow-up.
Mittal S, Wilkoff BL, Kennergren C, et al. · Heart Rhythm · 2020Multicenter Study, Randomized Controlled Trial
- Use of TYRX antibacterial envelope in inflatable penile prosthesis surgery: a prospective pilot study.
Rifkin JT, Baran JA, Im BH, et al. · J Sex Med · 2026Research Support, Non-U.S. Gov't
- Surgical management of "Twiddler syndrome" in patients with deep brain stimulation: a technical note and review of the literature.
Molle ZK, Slotty P, Vesper J · Acta Neurochir (Wien) · 2022Review, Research Support, Non-U.S. Gov't
- Differences between cardiac implantable electronic device envelopes evaluated in an animal model.
Ip JE, Xu L, Lerman BB · J Cardiovasc Electrophysiol · 2021
- Infections associated with cardiac electronic implantable devices: economic perspectives and impact of the TYRXࡊ antibacterial envelope.
Boriani G, Vitolo M, Wright DJ, et al. · Europace · 2021
Other devices of this type
Also filed under product code FTL.
- Focalseal-L Synthetic Absorbable SealantGenzyme Corp. · PMA 2003
- Focalseal-L Synthetic Ablsorbable SealantGenzyme Corp. · PMA 2001
- T-Line® Hernia MeshDeep Blue Medical Advances, Inc. · 510(k) 2023
- Parietene Macroporous Mesh (PPM5050 )Sofradim Production · 510(k) 2025
- ProGrip Self-Gripping Polypropylene MeshSofradim Production · 510(k) 2025
- VICRYL MeshETHICON, Inc. · 510(k) 2020
- VENTRALIGHT ST Mesh with ECHO 2 Positioning System 11cm (4.5) CircleC. R. Bard · 510(k) 2017
- Parietex Progrip Mesh (new name: Progrip Self-Gripping Polyester Mesh)Sofradim Production · 510(k) 2014
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.